Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Syncope: early-phase trial registry

2 of 13 indexed Syncope trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 2 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Syncope: 13 US clinical trials tracked, 2 recruiting.

Syncope is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Nationwide Children's Hospital, running 2 of these trials.

Enrollment posture brief

Registry condition syncope

OPEN 2 | RECR 15% | LATE 0 | EARLY 1 | RANK #1315 | SPON 2

Nearest open-share peer: Arthroplasty, Replacement, Knee (15% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Accidental Falls30.8%Actinic Keratoses23.1%Syncope (this)15%
Open-enrollment share among volume-matched conditions near Syncope

Syncope lists 2 open slots (15% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Syncope on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Syncope is recruiting below its size-band peers.

    2 of 13 indexed trials (15.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Syncope research.

    Nationwide Children's Hospital accounts for 2 of 13 trials (15.4%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Typical Syncope enrolment sits around 540 participants.

    Median target enrolment is 540 among the 12 trials that report a genuine target (sentinel values excluded). 4 of those (33.3%) plan for fewer than 100 participants.

  4. Syncope splits between interventional and observational designs.

    8 interventional and 5 observational studies make up this index (61.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

13 total, page 1 of 1

RECRUITING 600 participants

Genetic Markers of Cardiovascular Disease in Epilepsy

Mayo Clinic

NCT02824822

RECRUITING NA 200 participants

The Z Stitch Early Bed Rest Assessment Study

Oregon Health and Science University

NCT06087497

ACTIVE NOT RECRUITING 3,500 participants

BAsel Syncope EvaLuation (BASEL IX) Study

University Hospital, Basel, Switzerland

NCT01548352

ACTIVE NOT RECRUITING NA 1,080 participants

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

University of California, Los Angeles

NCT06526884

ACTIVE NOT RECRUITING NA 36 participants

Pediatric Adhesion and New Dermal Approach Study

iRhythm Technologies

NCT07118124

COMPLETED NA 1,820 participants

Oral Water Hydration to Prevent Post-Vaccination Presyncope

Duke University

NCT02353390

COMPLETED 1,297 participants

Practical Approaches to Care in Emergency Syncope

Columbia University

NCT04533425

COMPLETED 540 participants

Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis

St. Luke's-Roosevelt Hospital Center

NCT00764985

COMPLETED NA 123 participants

Evaluating an Emergency Department Observation Syncope Protocol for Older Adults

University of California, Los Angeles

NCT01003262

COMPLETED NA 95 participants

Qualitative Sweat Distribution During Tilt Table Procedure

Nationwide Children's Hospital

NCT02329548

COMPLETED Phase 2 50 participants

Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00093860

COMPLETED NA 20 participants

Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients

Nationwide Children's Hospital

NCT01795469

COMPLETED

Validation of the San Francisco Syncope Rule

Albert Einstein College of Medicine

NCT00300625

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Syncope records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Oral Water Hydration Other
1 trials
Application of the San Francisco Syncope Rule Procedure
1 trials
Unstructured, inpatient evaluation Other
1 trials
Emergency Department Observation Protocol Other
1 trials
Zoex compression garment Device
1 trials
Alizarin Red Other
1 trials
Next Day Clinic Other
1 trials
Zio monitor Device
1 trials

US sites by state

Facility locations filed on Syncope trials. A trial with sites in several states counts in each.

New York 3 trials
Massachusetts 3 trials
California 3 trials
Ohio 2 trials
North Carolina 2 trials
Texas 1 trials
Tennessee 1 trials
Oregon 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Syncope page

13 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Syncope condition card totals 13 registered trials; most-linked intervention Oral Water Hydration; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.